Research

Packages

Life of the unit

Next seminars

18 décembre 2018 à définir à définir

18 janvier 2019 à définir à définir

Last publications

Updated

Annie-Pierre Jonville-Bera

Situation

Poste : PH Pharmacologie
Institution : CHU de Tours

Publications scientifiques

Articles dans une revue internationale

• 1. Petitpain N, Argoullon L, Masmoudi K, Fedrizzi S, Cottin J, Latarche C, Mertes P, Gillet P, French Network of Regional Pharmacovigilance Centres (2018) Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012. Allergy, 73(11): 2224-33.
  
  
• 2. Danet C, Araujo M, Bos-Thompson M, Portolan G, Gautier S, Vanlemmens L, Bonenfant S, Jonville-Bera AP, Cottin J, Vial T, Bavoux F, Montastruc JL, Damase-Michel C, Benevent J, Bourgeois-Mondon I, Lacroix I (2018) Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiol Drug Saf: doi: 10.1002/pds.4689. [Epub ahead of print].
  
  
• 3. Sabatier R, Nicolas E, Paciencia M, Jonville-Bera AP, Madroszyk A, Cecile M, Braticevic C, Duran S, Tassy L, Rouby F, Micallef J, Rousseau F (2018) Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer. J Geriatr Oncol, 9(5): 494-500.
  
  
• 4. Cornillier H, Giraudeau B, Samimi M, Munck S, Hacard F, Jonville-Bera AP, Jegou M, d'Acremont G, Pham B, Chosidow O, Maruani A (2018) Effect of Diet in Chronic Spontaneous Urticaria: A Systematic Review. Acta Derm Venereol: doi: 10.2340/00015555-3015. [Epub ahead of print].
  
  
• 5. Ponard A, Ferreira-Maldent N, Ertault M, Delain M, Amraoui K, Regina S, Jonville-Bera AP, Hérault O, Colombat P, Gyan E (2018) Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report. J Med Case Rep, 12(1): 199. doi: 10.1186/s13256-018-1690-3.
  
  
• 6. Maruani A, Boccara O, Bessis D, Guibaud L, Vabres P, Mazereeuw-Hautier J, Barbarot S, Chiaverini C, Blaise S, Droitcourt C, Mallet S, Marlin S, Lorette G, Woillard J, Jonville-Bera AP, Rollin J, Gruel Y, Herbreteau D, Goga D, Le Touze A, Leducq S, Gissot V, Morel B, Tavernier E, Giraudeau B, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (2018) Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design. Trials, 19(1): doi: 10.1186/s13063-018-2725-1.
  
  
• 7. Cornillier H, Giraudeau B, Munck S, Hacard F, Jonville-Bera AP, d'Acremont G, Pham B, Maruani A (2018) Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol, 29(3): 303-10.
  
  
• 8. Bailly E, Von Tokarski F, Beau-Salinas F, Picon L, Miquelestorena-Standley E, Rousseau G, Jonville-Bera AP, Halimi JM (2018) Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. Am J Kidney Dis, 71(1): 142-5.
  
  
• 9. Bouquet E, Jourdain M, Machet M, Beau-Salinas F, Jonville-Bera AP (2017) Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review. Pediatr Blood Cancer, 64(11): doi: 10.1002/pbc.26597. Epub 2017 Apr 25.
  
  
• 10. Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier J, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C (2017) Psychiatric disorders, acne and systemic retinoids: comparison of risks. Expert Opin Drug Saf, 16(9): 989-95.
  
  
• 11. Cornillier H, Kervarrec T, Tabareau-Delalande F, Mammou S, Jonville-Bera AP, Machet L (2016) Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol, 26(6): 614-5.
  
  
• 12. Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean-Pastor M, Machet L, Jonville-Bera AP (2016) Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol, 175(5): 1067-9.
  
  
• 13. Kaguelidou F, Beau-Salinas F, Jonville-Bera AP, Jacqz-Aigrain E (2016) Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Br J Clin Pharmacol, 82(4): 1058-68.
  
  
• 14. Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen L, Bernard N, Vial T, Yates L, Pistelli A, Ellfolk M, Eleftheriou G, de Vries L, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology, 86(24): 2251-7.
  
  
• 15. Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A (2016) Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review. Acta Derm Venereol, 96(4): 448-52.
  
  
• 16. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvan T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, Pierre F, Collège National des Gynécologues Obstétriciens Français (2015) Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Eur J Obstet Gynecol Reprod Biol, 187: 80-4.
  
  
• 17. Bénard-Laribière A, Miremont-Salamé G, Perault-Pochat M, Noize P, Haramburu F, EMIR Study Group on behalf of the French network of Pharmacovigilance Centres (2015) Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol, 29(1): 106-11.
  
  

Chapitres d'ouvrage

• 1. Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
  
  
• 2. Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
  
  

Articles dans une revue nationale

• 1. Alami Z, Agier MS, Ahid S, Vial T, Dautriche A, Lagarce L, Toutain A, Cherrah Y, Jonville-Bera AP (2018) Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie, 73(3): 199-207.
  
  
• 2. Jonville-Bera AP (2018) [The pictogram "Drug and Pregnancy" : Good intentions but difficulties in sight]. Gynecol Obstet Fertil Senol, 46(5): 455-7.
  
  
• 3. Bouquet E, Star K, Jonville-Bera AP, Durrieu G (2018) Pharmacovigilance in pediatrics. Therapie, 73(2): 171-80.
  
  
• 4. Simon C, Lengellé C, Agier MS, Beau-Salinas F, Vrignaud L, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(11): 1150-7.
  
  
• 5. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(9): 906-7.
  
  
• 6. Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(8): 783-7.
  
  
• 7. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(5): 501-6.
  
  
• 8. Agier MS, Marchand S, Paret N, Gautier S, Jonville-Bera AP (2017) [Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr, 24(5): 439-44.
  
  
• 9. Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Perault-Pochat M, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P (2017) [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Rev Med Interne, 38(3): 167-75.
  
  
• 10. Agier MS, Beau-Salinas F, Bejan-Angoulvant T, Lengellé C, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(1): 81-6.
  
  
• 11. Agier MS, Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(11): 1204-16.
  
  
• 12. Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP (2016) [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod, 45(9): 1074-82.
  
  
• 13. Agier MS, Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(9): 1002-5.
  
  
• 14. Jonville-Bera AP, Mallaret M, Sgro C, Association Française des Centres Régionaux de Pharmacovigilance (2016) [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]. Thérapie, 71(4): 351-4.
  
  
• 15. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Agier MS, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(6): 646-52.
  
  
• 16. Jonville-Bera AP, Vial T, Sgro C, Mallaret M, Association Française des Centres Régionaux de Pharmacovigilance (2016) [On the absence of reimbursement of rotavirus vaccine in France]. Arch Pediatr, 23(6): 655-7.
  
  
• 17. Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(11): 1200-6.
  
  
• 18. Maruani A, Carriot M, Jonville-Bera AP, Lorette G, Gissot V, association Recommandations en Dermatologie (aRED) (2015) [Highlight on clinical research in pediatrics]. Ann Dermatol Venereol, 142(6): 446-9.
  
  
• 19. Bejan-Angoulvant T, Crochet J, Jonville-Bera AP (2015) [Calcium channel blockers pharmacology and their use as tocolytics]. J Gynecol Obstet Biol Reprod, 44(4): 305-11.
  
  
• 20. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(4): 440-6.
  
  
• 21. Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(2): .
  
  

Communications scientifiques

Poster dans un colloque national (idpers=1398)

• 1. Picard S., Leven C., Jonville-Bera A.P., Riche C., Perault-Pochat M., Lainé-Cessac P., Coquerel A., Jolliet P., Renaudineau E. Etude prospective sur les néphropathies immunoallergiques (NIA) médicamenteuses dans 11 unités françaises de néphrologie.9ème Congrès de Physiologie de Pharmacologie et de thérapeutique, Poitiers, 22-24 avril 2014, 2014.